Track topics on Twitter Track topics that are important to you
To expand its cardiac surgery portfolio, LivaNova PLC is paying $200mm to acquire private cardiopulmonary device maker TandemLife (formerly known as CardiacAssist). LivaNova could also hand over up to...
www.wallstequities.com/registration LivaNova On Thursday, shares in London, the UK headquartered LivaNova PLC recorded a trading volume of 235,958 shares. The stock ended the session Read more.....
LivaNova asked the CMS to reconsider its 2007 noncoverage determination for vagus nerve stimulation for treatment-resistant d -More-
LivaNova agreed to pay $200 million upfront plus up to $50 million in contingent payments based on regulatory milestones for -More-
The first patient in a postmarket study of LivaNova's VNS therapy system was enrolled at Universitatsklinikum Jena in Germany -More-
A prospective postmarket study was initiated by LivaNova to identify the overall incidence of reduced leaflet motion detected -More-
LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, will host a conference call to discuss its first quarter 2018 result...
LivaNova has obtained approval from Japan's Ministry of Health, Labor and Welfare for its Perceval sutureless aortic heart va -More-
Information on the long-term safety, efficacy and durability of third-generation stentless aortic valves is lacking.
Sutureless aortic valve prostheses are gaining popularity due to the substantial reduction in cross-clamp time. In this study, we report our observations on the cusp-fluttering phenomenon of the Perce...
Aortic stenosis is the most common valvular disease and has a dismal prognosis without surgical treatment. The aim of this meta-analysis was to quantitatively assess the comparative effectiveness of t...
Current retrospective evidence suggests similar clinical and superior hemodynamic outcomes of the Sorin Freedom Solo stentless aortic valve (SFS) (LivaNova PLC, London, UK) compared to the Carpentier ...
A global outbreak of infections due to Mycobacterium chimaera has been linked to the LivaNova (formerly Sorin) 3 T heater-cooler units (HCUs). We performed a study to investigate M. chimaera from HC...
This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a commercially approved L...
LivaNova PLCÂ is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Li...
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical devic...
We have published hundreds of LivaNova news stories on BioPortfolio along with dozens of LivaNova Clinical Trials and PubMed Articles about LivaNova for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LivaNova Companies in our database. You can also find out about relevant LivaNova Drugs and Medications on this site too.